BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32931481)

  • 1. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.
    Kong X; Zeng D; Wu X; Wang B; Yang S; Song Q; Zhu Y; Salas M; Qin H; Nasri U; Haas KM; Riggs AD; Nakamura R; Martin PJ; Huang A; Zeng D
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32931481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrafollicular CD4
    Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
    Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells, murine chronic graft-versus-host disease and autoimmunity.
    Eisenberg RA; Via CS
    J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.
    Young JS; Wu T; Chen Y; Zhao D; Liu H; Yi T; Johnston H; Racine J; Li X; Wang A; Todorov I; Zeng D
    J Immunol; 2012 Jul; 189(1):222-33. PubMed ID: 22649197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
    Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
    J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.
    Kong X; Wu X; Wang B; Zeng D; Cassady K; Nasri U; Zheng M; Wu A; Qin H; Tsai W; Salhotra A; Nakamura R; Martin PJ; Zeng D
    Blood; 2022 Dec; 140(25):2740-2753. PubMed ID: 36084473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.
    Nguyen V; Luzina I; Rus H; Tegla C; Chen C; Rus V
    J Immunol; 2012 Jul; 189(2):1081-93. PubMed ID: 22723520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity.
    Rus V; Nguyen V; Puliaev R; Puliaeva I; Zernetkina V; Luzina I; Papadimitriou JC; Via CS
    J Immunol; 2007 Mar; 178(6):3962-72. PubMed ID: 17339497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 Deficiency Ameliorates Chronic Graft-
    Martínez-Blanco Á; Domínguez-Pantoja M; Botía-Sánchez M; Pérez-Cabrera S; Bello-Iglesias N; Carrillo-Rodríguez P; Martin-Morales N; Lario-Simón A; Pérez-Sánchez-Cañete MM; Montosa-Hidalgo L; Guerrero-Fernández S; Longobardo-Polanco VM; Redondo-Sánchez S; Cornet-Gomez A; Torres-Sáez M; Fernández-Ibáñez A; Terrón-Camero L; Andrés-León E; O'Valle F; Merino R; Zubiaur M; Sancho J
    Front Immunol; 2021; 12():713697. PubMed ID: 34504495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
    Daenthanasanmak A; Iamsawat S; Chakraborty P; Nguyen HD; Bastian D; Liu C; Mehrotra S; Yu XZ
    Blood; 2019 Jan; 133(3):266-279. PubMed ID: 30514750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-Y Aggravates Murine Chronic Graft-
    Wan L; Jin Z; Hu B; Lv K; Lei L; Liu Y; Song Y; Zhu Y; Gong H; Xu M; Du Y; Xu Y; Liu H; Wu D; Liu Y
    Front Immunol; 2020; 11():559740. PubMed ID: 33329519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
    Asano T; Meguri Y; Yoshioka T; Kishi Y; Iwamoto M; Nakamura M; Sando Y; Yagita H; Koreth J; Kim HT; Alyea EP; Armand P; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Maeda Y; Tanimoto M; Ritz J; Matsuoka KI
    Blood; 2017 Apr; 129(15):2186-2197. PubMed ID: 28151427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.
    Deng R; Cassady K; Li X; Yao S; Zhang M; Racine J; Lin J; Chen L; Zeng D
    J Immunol; 2015 Jan; 194(2):560-74. PubMed ID: 25488990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
    Wu Y; Schutt S; Paz K; Zhang M; Flynn RP; Bastian D; Sofi MH; Nguyen H; Dai M; Liu C; Chang YJ; Blazar BR; Yu XZ
    Blood; 2018 Apr; 131(17):1974-1986. PubMed ID: 29530952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target antigens determine graft-versus-host disease phenotype.
    Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
    J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.